A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

UnitedHealthcare and Optum's struggles with an evolving Medicare Advantage market have investors questioning if valued-based care companies are at risk.

Due to the sharp price decline, the yield from the stock's dividend has climbed to 2.8%, which is higher than the S&P 500 ...